SCHEDULE 13D/AAccepted May 21, 4:46 PM ET
KalVista Pharmaceuticals, Inc. SCHEDULE 13D/A
Accepted (ET)
4:46 PM
May 21, 2026
Filed
May 21, 2026
Documents
3
Size
60.1 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.